GenomicDAO is a platform for integrating, initiating, advancing, and managing research and development in precision medicine; particularly focusing on underrepresented populations such as Asians, Hispanics, and Africans. GenomicDAO replaces the monopolistic precision health space, which has been dominated by a few countries and companies focused on European genomes, with democratized and decentralized management of precision medical research and development.
PCSP is the management and utility tool for stroke prevention within the GenomicDAO.
